Published in Surg Endosc on June 26, 2007
Metaanalysis of trials comparing minimally invasive and open distal pancreatectomies. Surg Endosc (2010) 1.18
Ten years of experience with resection of left-sided pancreatic ductal adenocarcinoma: evolution and initial experience to a laparoscopic approach. Surg Endosc (2010) 1.17
Prospective randomized comparison of clinical results between hand-assisted laparoscopic and open splenectomies. Surg Endosc (2009) 1.00
Hand-assisted laparoscopic versus laparoscopy-assisted D2 radical gastrectomy: a prospective study. Surg Endosc (2014) 0.94
Minimally invasive pancreatic surgery - a review. Wideochir Inne Tech Maloinwazyjne (2015) 0.86
Three-step hand-assisted laparoscopic surgery for radical distal gastrectomy: an effective surgical approach. Int J Clin Exp Med (2014) 0.84
Laparoscopic pancreatectomy: indications and outcomes. World J Gastroenterol (2014) 0.82
Gastric tube reconstruction by laparoscopy-assisted surgery attenuates postoperative systemic inflammatory response after esophagectomy for esophageal cancer. World J Surg (2010) 0.81
Laparoscopic pancreatic surgery: a review of present results and future prospects. HPB (Oxford) (2010) 0.79
Learning curve for hand-assisted laparoscopic D2 radical gastrectomy. World J Gastroenterol (2015) 0.75
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med (1992) 20.79
The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA (1995) 9.54
Safety and efficacy of laparoscopic cholecystectomy. A prospective analysis of 100 initial patients. Ann Surg (1991) 8.49
Complications of laparoscopic splenectomy. Arch Surg (2000) 2.71
Handoscopic surgery: a prospective multicenter trial of a minimally invasive technique for complex abdominal surgery. Southern Surgeons' Club Study Group. Arch Surg (1999) 2.06
Prospective randomized trial comparing conventional laparoscopic colectomy with hand-assisted laparoscopic colectomy: applicability, immediate clinical outcome, inflammatory response, and cost. Surg Endosc (2001) 1.86
Randomized controlled trial of laparoscopic versus open colectomy for advanced colorectal cancer. Surg Endosc (2003) 1.61
Randomized controlled trial of hand-assisted laparoscopic versus open surgical live donor nephrectomy. Transplantation (2001) 1.58
Hand-assisted laparoscopic colectomy vs open colectomy: a prospective randomized study. Surg Endosc (2004) 1.22
Hand-assisted laparoscopic surgery: an overview. Surg Endosc (2000) 1.20
Hand-assisted laparoscopic splenectomy. Surg Laparosc Endosc (1995) 1.14
Systemic inflammatory response syndrome and organ dysfunction following gastrointestinal surgery. Crit Care Med (1997) 1.14
Completely laparoscopic total and partial gastrectomy for benign and malignant diseases: a single institute's prospective analysis. J Am Coll Surg (2005) 1.06
Hand-assisted laparoscopic splenectomy vs conventional laparoscopic splenectomy in cases of splenomegaly. Arch Surg (2002) 0.97
Current status of laparoscopic surgery of the pancreas. J Hepatobiliary Pancreat Surg (1999) 0.92
Systemic inflammatory response syndrome in open versus laparoscopic adrenalectomy. Urology (2004) 0.88
Hand-assisted laparoscopic pylorus-preserving pancreaticoduodenectomy for pancreas head disease. Am J Surg (2005) 0.87
Current status and trends in laparoscopic antireflux surgery: results of a consensus meeting. The European Study Group for Antireflux Surgery (ESGARS). Endoscopy (1997) 0.85
Hand-assisted laparoscopic segmentectomy in recurrent pyogenic cholangitis. Surg Endosc (2002) 0.84
Antireflux surgery. Indications, preoperative evaluation, and outcome. Gastroenterol Clin North Am (1999) 0.83
Immunologic effects of hand-assisted surgery on peritoneal macrophages: comparison to open and standard laparoscopic approaches. Surgery (2006) 0.77
Hand-assisted laparoscopic resection of serous cystadenoma of the pancreas. Surg Endosc (2003) 0.75
[Assessment of surgical invasiveness of augmentation ileocystoplasty applying the systemic inflammatory response syndrome score in patients with spina bifida]. Nihon Hinyokika Gakkai Zasshi (2002) 0.75
Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK. J Clin Oncol (2009) 15.23
The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies. Cancer Cell (2006) 5.34
BIM mediates EGFR tyrosine kinase inhibitor-induced apoptosis in lung cancers with oncogenic EGFR mutations. PLoS Med (2007) 4.50
Differential effects of gefitinib and cetuximab on non-small-cell lung cancers bearing epidermal growth factor receptor mutations. J Natl Cancer Inst (2005) 4.19
Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancers dependent on the epidermal growth factor receptor pathway. Clin Lung Cancer (2009) 3.37
CSF concentration of the anaplastic lymphoma kinase inhibitor crizotinib. J Clin Oncol (2011) 3.00
EGFR exon 20 insertion mutations in non-small-cell lung cancer: preclinical data and clinical implications. Lancet Oncol (2011) 2.47
Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin. J Clin Invest (2004) 2.24
Combined vascular endothelial growth factor receptor and epidermal growth factor receptor (EGFR) blockade inhibits tumor growth in xenograft models of EGFR inhibitor resistance. Clin Cancer Res (2009) 2.04
Effects of erlotinib in EGFR mutated non-small cell lung cancers with resistance to gefitinib. Clin Cancer Res (2008) 2.00
NF-kappaB and AP-1 connection: mechanism of NF-kappaB-dependent regulation of AP-1 activity. Mol Cell Biol (2004) 1.96
Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistance. Cancer Res (2008) 1.95
Pooled analysis of the prospective trials of gefitinib monotherapy for EGFR-mutant non-small cell lung cancers. Lung Cancer (2007) 1.87
Laparoscopic total gastrectomy with D2 lymph node dissection for gastric cancer. Arch Surg (2009) 1.80
Novel PINK1 mutations in early-onset parkinsonism. Ann Neurol (2004) 1.72
Placement of a metallic stent across the main duodenal papilla may predispose to cholangitis. Gastrointest Endosc (2006) 1.69
Negative impact of blood transfusion on recurrence and prognosis of hepatocellular carcinoma after hepatic resection. J Gastrointest Surg (2009) 1.69
Preclinical rationale for use of the clinically available multitargeted tyrosine kinase inhibitor crizotinib in ROS1-translocated lung cancer. J Thorac Oncol (2012) 1.66
Dual specificity phosphatase 6 (DUSP6) is an ETS-regulated negative feedback mediator of oncogenic ERK signaling in lung cancer cells. Carcinogenesis (2010) 1.64
A distal single nucleotide polymorphism alters long-range regulation of the PU.1 gene in acute myeloid leukemia. J Clin Invest (2007) 1.63
Clinical significance of TROP2 expression in colorectal cancer. Clin Cancer Res (2006) 1.61
Evaluation of nonstructural 1 protein rapid test for dengue virus at the Narita Airport quarantine station, Japan. Jpn J Infect Dis (2011) 1.61
Carba analogs of cyclic phosphatidic acid are selective inhibitors of autotaxin and cancer cell invasion and metastasis. J Biol Chem (2006) 1.61
Donor complications associated with living donor liver transplantation in Japan. Transplantation (2009) 1.60
Differential responses to erlotinib in epidermal growth factor receptor (EGFR)-mutated lung cancers with acquired resistance to gefitinib carrying the L747S or T790M secondary mutations. J Clin Oncol (2008) 1.53
EGFR-mutated lung cancer: a paradigm of molecular oncology. Oncotarget (2010) 1.53
Outcomes of living donor liver transplantation for hepatitis C virus-positive recipients in Japan: results of a nationwide survey. Transpl Int (2014) 1.49
Dioxin-induced fetal growth retardation: the role of a preceding attenuation in the circulating level of glucocorticoid. Endocrine (2014) 1.44
Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations. J Thorac Oncol (2010) 1.42
Engineered interface of magnetic oxides. Science (2004) 1.42
Resistance to an irreversible epidermal growth factor receptor (EGFR) inhibitor in EGFR-mutant lung cancer reveals novel treatment strategies. Cancer Res (2007) 1.41
Changes in serum levels of hepatocyte growth factor in patients undergoing adult-to-adult living-donor liver transplantation. Transplantation (2003) 1.40
Combined ascorbic acid and sodium nitrite treatment induces oxidative DNA damage-associated mutagenicity in vitro, but lacks initiation activity in rat forestomach epithelium. Toxicol Sci (2008) 1.40
Primary small-cell neuroendocrine carcinoma of the breast: report of a case. Surg Today (2008) 1.39
Laparoscopic versus open D2 gastrectomy for advanced gastric cancer: a retrospective cohort study. Surg Endosc (2012) 1.36
Effect of grain colour gene (R) on grain dormancy and sensitivity of the embryo to abscisic acid (ABA) in wheat. J Exp Bot (2002) 1.33
Human prorenin has "gate and handle" regions for its non-proteolytic activation. J Biol Chem (2003) 1.30
CD147 and matrix metalloproteinase-2 protein expression as significant prognostic factors in esophageal squamous cell carcinoma. Cancer (2004) 1.27
Remote asymmetric induction with vinylketene silyl n,o-acetal. J Am Chem Soc (2004) 1.22
Apoptosis induced by JAK2 inhibition is mediated by Bim and enhanced by the BH3 mimetic ABT-737 in JAK2 mutant human erythroid cells. Blood (2010) 1.21
Absence of the transcription factor CCAAT enhancer binding protein alpha results in loss of myeloid identity in bcr/abl-induced malignancy. Proc Natl Acad Sci U S A (2006) 1.20
Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma. Surgery (2003) 1.20
The advantages and disadvantages of a Roux-en-Y reconstruction after a distal gastrectomy for gastric cancer. Surg Today (2009) 1.18
A simple and novel technique for the placement of antiadhesive membrane in laparoscopic surgery. Surg Laparosc Endosc Percutan Tech (2008) 1.18
Elevation of cell proliferation via generation of reactive oxygen species by piperonyl butoxide contributes to its liver tumor-promoting effects in mice. Arch Toxicol (2010) 1.17
Glucuronidation and the UDP-glucuronosyltransferases in health and disease. Drug Metab Dispos (2004) 1.15
Wandering spleen with chronic torsion. Am J Surg (2008) 1.14
Comparison of anchoring capacity of mesh fixation devices in ventral hernia surgery. Surg Laparosc Endosc Percutan Tech (2009) 1.14
Frequent detection of K-ras mutation in stool samples of colorectal carcinoma patients after improved DNA extraction: comparison with tissue samples. Int J Oncol (2002) 1.10
Inhibition of transcellular tumor cell migration and metastasis by novel carba-derivatives of cyclic phosphatidic acid. Biochim Biophys Acta (2006) 1.10
Serum vitamin D levels and survival of patients with colorectal cancer: post-hoc analysis of a prospective cohort study. BMC Cancer (2010) 1.09
Inhibition of lung cancer growth: ATP citrate lyase knockdown and statin treatment leads to dual blockade of mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3-kinase (PI3K)/AKT pathways. J Cell Physiol (2012) 1.08
Hemangiopericytoma of the greater omentum. J Gastrointest Surg (2007) 1.08
Doxycycline induces apoptosis in PANC-1 pancreatic cancer cells. Anticancer Res (2009) 1.07
Implantation of rectal cancer in an anal fistula: report of a case. Surg Today (2006) 1.07
Reconstituted high-density lipoprotein stimulates differentiation of endothelial progenitor cells and enhances ischemia-induced angiogenesis. Arterioscler Thromb Vasc Biol (2007) 1.06
Importance of preoperative imaging with 64-row three-dimensional multidetector computed tomography for safer video-assisted thoracic surgery in lung cancer. Surg Today (2009) 1.05
A crucial role of Nrf2 in in vivo defense against oxidative damage by an environmental pollutant, pentachlorophenol. Toxicol Sci (2005) 1.05
Clinical usefulness of diffusion-weighted imaging using low and high b-values to detect rectal cancer. Magn Reson Med Sci (2006) 1.03
Preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for the evaluation of curability and resectability in patients with pancreatic adenocarcinoma. J Hepatobiliary Pancreat Surg (2007) 1.03
Synergistic induction of antigen-specific CTL by fusions of TLR-stimulated dendritic cells and heat-stressed tumor cells. J Immunol (2007) 1.02
A 16-year experience in performing hepatic resection in 303 patients with hepatocellular carcinoma: 1985-2000. Surgery (2002) 1.01
Pulmonary vein analysis using three-dimensional computed tomography angiography for thoracic surgery. Gen Thorac Cardiovasc Surg (2010) 1.01
Biological functions of a novel lipid mediator, cyclic phosphatidic acid. Biochim Biophys Acta (2002) 1.00
Streptococcal preparation OK-432 promotes fusion efficiency and enhances induction of antigen-specific CTL by fusions of dendritic cells and colorectal cancer cells. J Immunol (2007) 1.00
CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer binding protein alpha. Blood (2007) 1.00
A new antibiotic, antimycin Ag, produced by Streptomyces sp. K01-0031. J Antibiot (Tokyo) (2005) 0.99
Relationship between portal venous flow and liver regeneration in patients after living donor right-lobe liver transplantation. Liver Transpl (2003) 0.99
Small symptomatic pericardial diverticula treated by video-assisted thoracic surgical resection. Ann Thorac Cardiovasc Surg (2009) 0.99
Steryl glucoside is a lipid mediator in stress-responsive signal transduction. Cell Struct Funct (2002) 0.99
CARM1 is required for proper control of proliferation and differentiation of pulmonary epithelial cells. Development (2010) 0.99
Protective effects of benzyl isothiocyanate and sulforaphane but not resveratrol against initiation of pancreatic carcinogenesis in hamsters. Cancer Lett (2006) 0.99
Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma. Int J Cancer (2013) 0.99
Inhibition of UDP-glucuronosyltransferase 2b7-catalyzed morphine glucuronidation by ketoconazole: dual mechanisms involving a novel noncompetitive mode. Drug Metab Dispos (2006) 0.98
Knife blade penetrating stab wound to the brain--case report--. Neurol Med Chir (Tokyo) (2005) 0.98
Nuclear factor kappa B activation is a potential target for preventing pancreatic carcinoma by aspirin. Cancer (2005) 0.97
Intrahepatic cholangiocarcinoma mimicking hepatic inflammatory pseudotumor. J Gastrointest Surg (2007) 0.97
Reasons and risk factors for intraoperative conversion from laparoscopic to open cholecystectomy. Surg Today (2012) 0.97
Successful treatment of advanced gallbladder cancer with an anticancer drug S-1: assessment based on intratumoral gene. Int J Clin Oncol (2008) 0.96
Dendritic cells fused with allogeneic colorectal cancer cell line present multiple colorectal cancer-specific antigens and induce antitumor immunity against autologous tumor cells. Clin Cancer Res (2005) 0.96
Anomalous pulmonary vein detected using three-dimensional computed tomography in a patient with lung cancer undergoing thoracoscopic lobectomy. Gen Thorac Cardiovasc Surg (2008) 0.96